Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Warfarin Initiation and Management

Initial Dosing Strategy

  • For outpatients, the American College of Cardiology recommends starting warfarin at 10 mg daily for the first 2 days, then adjusting based on INR measurements, which achieves therapeutic INR faster than 5 mg initiation 1
  • A 10 mg loading approach results in 86% of patients achieving therapeutic INR by day 5, compared to 45% with 5 mg dosing 1
  • The American Heart Association notes that elderly patients require approximately 1 mg/day less than younger individuals due to higher bleeding risk, although this specific guideline is from the American College of Cardiology 3

Concurrent Heparin Bridging

  • When rapid anticoagulation is required, heparin should be started concurrently with warfarin on day 1 and continued for at least 4-5 days until therapeutic INR is achieved, as recommended by the American College of Chest Physicians 1
  • Early warfarin initiation reduces hospital utilization by approximately 4 days compared to delayed initiation, according to the American College of Chest Physicians 1
  • Heparin overlap should be continued until INR is therapeutic for at least 24 hours and preferably 2 consecutive days, as per the American College of Chest Physicians guidelines 1

INR Monitoring Schedule

  • After achieving stable therapeutic INR, the American Heart Association recommends monitoring 2-3 times weekly for 1-2 weeks 2
  • Once stable on maintenance dose, INR should be checked every 3-4 days initially, as suggested by the American College of Cardiology 3
  • Long-term stable patients can have INR checked as infrequently as every 4 weeks, according to the American Heart Association 2, 3

Target INR Ranges

  • For most indications, including atrial fibrillation, venous thromboembolism, and stroke prevention, the American College of Cardiology recommends targeting an INR of 2.0-3.0 3
  • Mechanical prosthetic valves may require higher intensity anticoagulation, with an INR of 2.5-3.5 or 3.0-4.0, as recommended by the American Heart Association 4, 3

Special Population Considerations

  • For pregnant patients with mechanical heart valves, if warfarin dose ≤5 mg/day, continuation throughout pregnancy may be reasonable after informed consent, according to the American College of Cardiology 2, 3
  • If warfarin dose >5 mg/day, switching to dose-adjusted LMWH during the first trimester is recommended due to >30% fetal loss/embryopathy risk, as suggested by the American College of Cardiology 2, 3

Critical Pitfalls to Avoid

  • The American College of Cardiology recommends avoiding loading doses when restarting warfarin after interruption, as this increases hemorrhagic risk without providing faster protection 3
  • Unexpected INR fluctuations can occur due to changes in diet, concurrent medications, poor compliance, or alcohol consumption, according to the American Heart Association 2
  • A disproportionate number of thromboembolic and bleeding events occur when INR is outside therapeutic range, as noted by the American College of Cardiology 2